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IT has been shown (Ada and Perry, 1955, 1956) that theinfectivity ofinfluenza
virus can be correlated with the amount of ribonucleic acid (RNA) in the virus
preparations. Partially purified virus extracts from tumours such as the Rous
No. 1 sarcoma are probably relatively impure compared with influenza virus
preparations because of the lack of specific reactions whereby the virus can be
separated from non-infective tumour cell cytoplasmic components. It was felt,
however, that it would be worth while investigaating tumour virus concentrates
for possible clues as to the relative importance ofthe nucleic acid, lipid or protein
constituents to the infectivity of the extracts. It has already been shown that
RNA can be quantitatively extracted and is probably the exclusive nucleic
acid type found in Rous sarcoma virus preparations (Bather, 1957).
MATERIALS AND METHODS
All the methods employed in the titration of infectivity, isolation of the
partially purified virus, the chemical estimations of RNA and lipid and the deter-
mination ofthe molecular proportions ofpurines andpyrimidines in the RNA have
been described in detail elsewhere (Bather, 1953, 1957). Briefly, the infectivity
titrations employ serial dilution and end-point determination in day-old chicks.
Fractional centrifugation and enzyme treatment with hyaluronidase and trypsin
were used in the purification procedure. RNA was determined, after extraction
with 10 per cent NaCl, by its absorption at 260 m, in the spectrophotometer.
Lipid was extracted from the dried, weighed virus preparation and its amount
estimated by the difference in the weight of the delipidated material. Purine
bases and pyrimidine nucleotides were separated from acid digests by paper
chromatography and their relative amounts estimated by eluting and reading
their absorption in the U.V. spectrophotometer. The chickens, as before, were
from the inbred line ofhigh Rous susceptibility maintained at the Centre.
Four tumours which have not been described before were used in this work.
Three ofthem are fibro-myxo-sarcomata (P.R.C.-2, -3 and -4) and containinfective
viruses. P.R.C.-2 arose in the mesentery of a chicken of unknown strain.
P.R.C.-3 was found in the breast muscle of a Rhode Island Red hen. P.R.C.-4
arose either in the mesentery or the ovary of a Light Sussex hen. All three were
maintained by serial passage in the breast muscle of young Brown Leghorn
chickensfrom the flock at this Centre. Frozen dried preparations have been made
of each and are kept in cold storage. P.R.C.-1 is a very fast growing myelo-INFECTIVITY AND RNA CONTENT OF ROUS VIRUS
blastoma with leukaemic tendencies. It first appeared in a Brown Leghorn
hen from our own flock as a myeloid leukaemia. Upon transplantation of homo-
genized spleen tissue it was found to grow as a solid myeloblastoma which often
metastasized to the liver, lungs and kidney in the early passages. From the 27th
passage on, however, metastases almost never occurred and the leukaemic
condition became much more severe, probably causing the death of the host.
It has no virus associated with it despite its very rapid growth which results in
the death of the bird 6 or 7 days after transplantation.
EXPERIMENTAL
Correlktion ofRNA content ofpartially purified Rous virus with infectivity
A series of33 virus prepa.rations wasexamined forRNA content andinfectivity.
RNA phosphorus was converted to RNA by applying the factor 9-7 calculated
from the known proportions of bases estimated by paper chromatography and
U.V. absorption (Bather, 1957). Four or five chicks were used at each dilution
in the infectivity titration and the second figure in the end-point estimated by
the method of Parker and Rivers (1936). Infectivity is expressed as Minimum
Infective Doses per g. wet tumour (M.I.D./g. tumour). The results are plotted
in Fig. 1.
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FIG. 1.-Relationship between infectivity and ribonucleic acid content of
partially purified Rous sarcoma virus preparations.
The range of infectivities extends from 10 M.I.D./g. tumour to 106.5 M.I.D./g.
and represents almost as wide a range as it is possible to get with Rous Sarcoma
grown inyoung oradult chickens. Most ofthe preparations oflowinfectivity were
obtained from adult hosts oftwo or more years ofage. The rate ofgrowth ofthe
tumours was fairly uniform over the whole range. That there is an increase in
RNA content in preparations of high infectivity is obvious from the graph.
The correlation was examined statistically and found to be highly significant
(r = 0-643 for 31 degrees offreedom-see Table II). The equation of the regres-
sion line for the data is y = 3 41x + 0-29 and has been drawn in Fig. 1.
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RNA content of lipid-free Rous sarcoma virus preparations
Uhler and Gard (1954) put forward evidence that the lower density of incom-
plete influenza virus as compared with standard preparations was due to a higher
lipid content. It was considered advisable to follow the lipid content of the
partially purified Rous virus preparations in order to see if any difference could
be detected between preparations of low and high infectivity. The amount of
lipid was estimated by weighing dry virus preparations before and after extraction
with a chloroform: methanol mixture (2: 1) and ether. It was then possible
to express RNA as percentage of the lipid-free residue.
Table I presents these results grouped into three levels ofinfectivity and gives
the average percentage RNA in the whole unfractionated preparations and in
TABLE I.-Ribonucleic Acid and Lipid Content of Partially Purified Rous sarcoma
Virus Preparations ofLow, Medium and High Infectivity
Average % RNA Average % RNA Average % lipid
in whole in lipid-free in whole
preparations preparations preparation
Infectivity Number of ±S.D. ±S.D. ±S.D.
M.I.D.fg. observations (range) (range) (range)
10-103- . 7 . 0-94±0-21 . 1-71±0-31 . 451±12*5
(0*62-1*15) (1*24-2*50) (25*0-60*4)
10331_105.0 10 . 1*27+0-20 2*3840-44 . 46 1±6-3
(0*91-1*57) (1*92-3*14) (40*6-57*5)
105.3-l06.5 16 . 1-47±0- 24 2-46±0-62 . 3907 7
(1*05-1*84) (1*48-3*46) (23*4-49*9)
the lipid-free residues and the average percentage lipid of the whole preparations.
The range of values is given in brackets beneath the averages.
There seems to be a trend towards increasing lipid content in preparations of
low infectivity (final column). However, the results are widely scattered and
there is no significant correlation when the data are examined statistically. The
correlation between RNA content andinfectivity, whether expressed as percentage
of the whole unfractionated preparation or as percentage of the lipid-free residue
is statistically significant in both cases (even though the wide scatter in the lipid
results has imparted a correspondingly wide scatter to the values ofRNA content
of the lipid-free residues). The slopes of the regression lines are, however, quite
different for the two sets of data. The pertinent statistical data are given in
Table II.
TABLE II.-Statistical Correlations between the Infectivity ofPartially Purified Rous
Sarcoma Virus Preparations and their RNA and Lipid Content
Coefficient of Slope of
Con-stituent of correlation regression mine Significance
preparation (" r ") (" b ") (" P")
RNA in whole preparation. . 0 643 . 3.41* . <0001
RNA in lipid-free preparation . 0-529 . 1 60 . <0-01
Lipid in extract . . . 0*134 . - . >01
* Equationi of regression line y = 3 -41x + 0*29.
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Molecular proportions of purine and pyrimidine bases in RNA isolated from
different tumours and normal tissues of thefowl
The series of virus induced tumours available in this laboratory was examined
with respect to the relative amounts of purines and pyrimidines in the partially
purified virus RNA. These are Rous Sarcoma, P.R.C.-2, -3, and -4 sarcomata
and MH2 endothelioma. In addition P.R.C.-1 (non-virus associated myeloid
tumour) and GRCH/16 (a non-virus associated descendant of a chemically-
induced sarcoma) were extracted in the same way as the virus-induced tumours.
The cytoplasmic particulate fraction was " purified " by enzyme treatment and
fractional centrifugation as if a virus were present. The resulting " partially
purified pellet " was treated in exactly the same way as those from the virus-
induced tumours in order to obtain the RNA and examine its purine and pyrimi-
dine composition. The same procedure was followed in isolating the RNA from
normal liver and spleen extracts. The combined results are presented in Table
III. The amounts of RNA found in the virus and particulate preparations from
all the tumours studied were similar and lay within the range found for Rous
sarcoma. This was also true for the lipid content.
TABLE III.-Molecular Proportions of Purine and Pyrimidine Bases Obtained
bi Chromatographic Separation on Filter Paper of RNA from Yeast, Partially
Purified Tumaur Virus Preparations and( Cytoplsmic Concentrates of Fowl
Liver, Spleen and Non-virus Associated Tumours.
Number
Source of A + U Pu A + C
of obser- Ade- Guanine Cytosine Uracil G + C Py G + U
RNA vations nine ± S.D. ± S.D. ± S.D. ± S.D. ± S.D. ± S.D.
Yeast . 10 . 1.00 115±0-04 . 0-82±0-01 . 0-88±0-02 . 0-96±002 . 1-27±0-03 0-89±0-02
Rous . 9 . 100 . 1-86±0-12 . 1-59±0-06 . 083±0-07 . 0-53±0 03 . 1b19±0-04 . 0-96±002
sarcoma
'RC-2 . 4 . 100 . 183+018 . 1 53±0-09 . 0 78±0 09 . 0.53+002 123±0 03 . 0-96±0-04
RC-3 . 1 . 1.00 . 1-73 . 1-41 . 0-76 . 0-56 . 1-25 1 06
IRC-4 . 1 1.00 . 1-85 . 1*66 . 0 97 . 0-56 . 1.08 0-94
MH2 . 1 1.00 . 2-12 . 1-59 . 0-91 . 0-50 1-20 . 0-87
GRCH/16. 3 . 1-00 . 1-83±0-11 . 1-49±0-10 . 0-79±0-07 . 0-54±0-04 . 1-23±0-03 0-93±0-05
PRC-1 . 5 1-00 . 2-08±0-16 1-62±0-08 . 0-860-09 . 0-50±0-02 . 1-24±0-05 . 0-90±0-07
Spleen . 4 . 1-00 . 1-98+0-11 1-54+0-13 . 0-81+0-08 . 0-52+0-01 . 1-27+0-05 . 0-92+0-06
Liver . 2 . 1-00 . 1-81 . 1-58 . 0-71 . 0-51 . 1-23 . 1-02
(1*78-1.84) (1-62-1-54) (0-67-0-75) (0.49-0.52) (1.22-1.24) (1.07-0-98)
All of the values for the purine and pyrimidine bases are referred to adenine
(= 1.00) and presented with their standard deviation (S.D. = en6xi ). The last
three columns are ratios between different pairs ofbases. The first ofthese shows
the ratio of adenine + uracil to guanine + cytosine obtained for RNA from yeast
and tumour or normal tissue sources. The low values for nucleic acids other than
yeast are typical and the predominance ofguanine and cytosine has been commen-
ted on by Elson and Chargaff (1954). The ra.tios appear to be the same, within
experimental error, for all samples except yeast, with the possible exception of
MH2 endothelioma and P.R.C.-1 myeloblastoma, but the differences are very
small and not significant (p>0-05 by the t-test).
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The ratios ofpurines to pyrimidines are fairly constant throughout and always
greater than unity. The last column (adenine + cytosine: guanine + uracil)
gives a measure ofthe ratio of6-keto groups to 6-amino groups and is ofinterest in
the possible configuration of the RNA molecule. In each case the ratio is close
to unity and these results are in agreement with the general observations ofElson
and Chargaff (1954). There are no significant differences between the ratios of
purines to pyrimidines or adenine + cytosine/guanine + uracil for any pair of
results in the table.
In order to see if there were any detectable differences in the nucleic acid
composition between Rous sarcoma virus preparations oflow and high infectivity,
the three oflowest and the three ofhighest infectivity were compared (Table IV).
TABLE IV.-Relative Proportions of Purine and Pyrimidine Bases in the RNA
Isolated from Partially Purified Rous Sarcoma Virus of Low and High
Infectivity
Number of Infectivity Guanine Cytosine Uracil A + U
observations M.I.D./g Adenine ± S.D. ± S.D. ± S.D. G + C ± SD
3 . 1O-03' .7 1.00 1 95+0 05 . 159±0-09 . 0-87±4 0*07 . 0-53±0-02
3 . 1053-106 . 100 . 1*86±019 . 1*65±0-09 . 083±005 . 0 53±004
The ratios of adenine + uracil to guanine + cytosine were the same in both
cases and there was no evidence of any change in the relative proportions of
nitrogenous bases being involved at different levels ofinfectivity.
DISCUSSION
The positive correlation between RNA content and infectivity (Fig. 1) is not
a simple proportionality, but involves an approximate doubling of RNA content
for a 2 X 103 increase in infectivity. If the RNA content of the lipid-free
material only is considered the slope of the regression line then becomes smaller
and a doubling ofRNA content occurs for a 40-fold increase in infectivity. These
correlations are statistically significant in spite ofa wide variation in the amounts
of RNA present in the extracts at each level of infectivity. It appears, then,
that although the partially purified preparations of virus used in this work may
not be as pure as those used in other fields, it is still possible to pick up changes in
gross chemical composition and relate them to a biological function such as
infectivity.
The relative importance of the lipid portion of the virus is not clear. The
extreme sensitivity of Rous virus to organic solvents is well known and Claude
(1939) was the first to suggest that the aldehyde properties of the lipid fraction
mayplay a part inthe spontaneous and rapid inactivation ofthe agent. Recently
Moloney (1957) was able to show that oxidation products ofRous tumourlecithin, microsome lipids and methyl linolate would inhibit infectivity of Rous virus, especially in phosphate buffer. A tendency towards increasing lipid content in
preparations oflow infectivity did appear to be present in the observations made
here but the variation was extremely great and the tendency was not significant
(Tables I and II).
The importance of nucleic acid to the infectivity and growth of viruses of all
types has been emphasized in recent years and in the case of the bacteriophages,
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it is almost certain that only the nucleic acid is involved in their intracellular
multiplication (Hershey and Chase, 1952). Tobacco Mosaic virus too has received
considerable attention and Gierer and Schramm (1956) presented evidence that
RNA from phenol extracted Tobacc6 Mosaic virus possesses a definite, though
transient, infectivity. Reports from various laboratories have confirmed that
it is possible to degrade the virus into native protein and nucleic acid and under
the right conditions to mix the parts and obtain a significant rise in infectivity
(Schramm, 1947; Fraenkel-Conrat and Williams, 1955; Lippincott and
Commoner, 1956; Commoner et al., 1956). Whether this phenomenon is due to
actual re-assembly of non-infective components into infective virus or is brought
about by the removal of inhibitors or stabilization of otherwise labile infective
fragments is open to question (Bawden and Pirie, 1957). In any case these
experiments all point to the essential condition of nucleic acid integrity for
biological activity of the viruses so far studied in this respect.
It was disappointing, therefore, to find no evidence of specificity in the purine
and pyrimidine ratios in any ofthe partially purified virus or cytoplasmic particle
extracts studied, even when the tumours were of different types (i.e. spindle-cell
sarcoma and myeloid tumour). Ifthere are small differences they may be masked
by the wide variability ofthe results. This variability, in turn, may be due either
to enzymatic degradation or to the presence of more than one type of RNA with
different proportions ofnitrogenous bases. Colter and Brown (1956) showed that
the RNA obtained from the cytoplasm ofEhrlich ascites cells by phenol extraction
has two main components of different molecular weights which can be separated
in the analytical ultracentrifuge, or by precipitation with 1 M NaCl. The high
Molecular weight component also appears to be heterogeneous and the base
ratios of the low and high molecular weight components are quite different
(Brown et al., 1957). It may be necessary, therefore, to fractionate the RNA
from tumour virus concentrates in order to show any differences in molecular
composition between preparations from different sources.
Care was taken in these experiments to select tumours of rapid and constant
growth rates. It is unlikely, therefore, that the increase in RNA content seen
in the Rous virus preparations of high infectivity is simply a reflection of an
increased growth rate of the host tumour. Because of the readiness with which
Rous virus becomes inactivated, care was taken to ensure that the least possible
time elapsed between the sacrifice ofthe bird and the titration of the final centri-
fuged pellet. An approximately constant time of five hours was allowed for
processing of the tumour extracts from the death of the bird to the titration of
tumour infectivity. The partially purified extract was frozen for storage
immediately before the titration was done.
It would be dangerous at the present time to be too dogmatic about the reasons
for the higher RNA content in extracts of high infectivity. However, the work
of Epstein (1956, 1957) in correlating infectivity with the increase in a specific
type ofmorphologically distinct particle in Rous ascites cells is provoking. These
particles have the usual physical characteristics associated with animal viruses,
namely, a single or sometimes double outer membrane, a viroplasm and an inner
membrane surrounding an electron dense nucleus. Similar particles have been
seen by Gaylord (1955) and Bernhard, Oberling and Vigier (1956) in the cytoplasm
of Rous cells or in the inter-cellular spaces. There is some evidence that such
virus-like particles may be present in normal fowl tissues but in much reduced
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numbers as compared with malignant cells (Rouiller, Haguenau, Golde and Lacour,
1956; Benedetti, Bernhard and Oberling, 1956). The presence of virus-like
bodies has also been reported in normal chick embryo tissue culture cells (Gey
and Bang, 1951; Bang, 1952; Gey, Bang and Gey, 1954). However, the biolo-
gical correlation observed by Epstein helps to implicate particles of this type in
in the formation of tumours and may explain, at least in part, the rise in RNA
level observed in the experiments reported here. Although Bernhard, Oberling
and Vigier (1956) were able to find only a few obvious virus-like particles in their
partially purified Rous virus pellets, the relatively large amount of electron-
dense material in the nucleus may indicate a higher level of nucleic acid in these
particles than in the surrounding microsomal material. Thus their contribution
to the total RNA percentage may be enough to account for the observed changes
with infectivity.
SUMMARY
Thirty-three partially purified Rous No. 1 sarcoma virus preparations were
examined for RNA content, lipid content and infectivity. A highly significant
positive correlation was found to exist between the percentage RNA ofthe whole
preparations and their infectivity (r = 0-643 for 31 degrees of freedom). A
significant positive correlation also existed between infectivity and the RNA
content of lipid-free virus preparations (r = 0-529 for 31 degrees of freedom).
No significant correlation was found betweenlipid content and infectivity although
a tendency towards a lower lipid content in preparations of high infectivity did
occur.
The amounts of RNA in the Rous virus preparations were between 0-62 and
184 per cent. The amounts of lipid were between 23-4 and 60-4 per cent. All
the virus and particulate preparations from the tumours studied contained
similar amounts ofRNA and lipid to those found in the Rous preparations.
The molecular proportions of purine and pyrimidine bases were determined in
the RNA isolated from the virus preparations from different fowl tumours as
well as from the corresponding particulate fraction, from non-virus associated
tumours and normal tissues. The ratios adenine + uracil/guanine + cytosine
forthe various samples showed no significant differences between any ofthe malig-
nant or normal fowl tissues studied. Neither did the ratios adenine + cytosine/
guanine + uracil, nor the ratios of purines to pyrimidines. When RNA from
Rous virus preparations of high and low infectivity were examined for purine
and pyrimidine composition it was again impossible to detect any differences
between either the proportions of individual bases or the ratio adenine + uracil/
guanine + cytosine.
The above results are discussed in relation to the work on other viruses and the
special difficulties with tumour viruses.
All expenses in connection with this work were borne by the British Empire
Cancer Campaign.
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